Silence Therapeutics plc (SLN)

NASDAQ: SLN · IEX Real-Time Price · USD

18.06

-0.68 (-3.63%)

Jul 2, 2024, 4:00 PM EDT - Market closed

Silence Therapeutics Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-43.27	-40.49	-39.41	-32.55	-19.58	Upgrade
Depreciation & Amortization	0.46	0.48	0.41	0.48	0.45	Upgrade
Share-Based Compensation	13.05	10.25	8.63	4.4	0.58	Upgrade
Other Operating Activities	-9.6	-15.7	37.17	16.9	20.27	Upgrade
Operating Cash Flow	-39.35	-45.46	6.81	-10.78	1.73	Upgrade
Capital Expenditures	-0.05	-0.14	-1.31	-0.51	-0.01	Upgrade
Change in Investments	15.52	-16.13	10	10	-15	Upgrade
Other Investing Activities	0.96	-0.28	-0.01	0.13	-0.01	Upgrade
Investing Cash Flow	16.43	-16.54	8.68	9.62	-15.02	Upgrade
Share Issuance / Repurchase	25.33	43.24	30.92	15.83	5.27	Upgrade
Debt Issued / Paid	-0.17	-0.19	-0.21	-0.4	0	Upgrade
Financing Cash Flow	25.16	43.05	30.71	15.43	5.27	Upgrade
Exchange Rate Effect	-3.02	0.23	-0.11	-0.34	0.04	Upgrade
Net Cash Flow	2.24	-18.95	46.19	14.27	-8.02	Upgrade
Free Cash Flow	-39.4	-45.6	5.5	-11.28	1.72	Upgrade
Free Cash Flow Margin	-155.25%	-260.53%	44.26%	-205.95%	704.10%	Upgrade
Free Cash Flow Per Share	-1.02	-1.27	0.18	-0.43	0.07	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).